We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Proteomic Biomarkers in Thyroid Cancer

News   Mar 14, 2017 | Written by Louise Saul

 
Proteomic Biomarkers in Thyroid Cancer
 
 
Advertisement
 

RELATED ARTICLES

Structure of Potent Antibody Against SARS-CoV-2 Is Mapped

News

Scientists at Fred Hutchinson Cancer Research Center in Seattle have shown that a potent antibody from a COVID-19 survivor interferes with a key feature on the surface of the coronavirus’s distinctive spikes, causing them to drop off.

READ MORE

Biomarkers Could Be Used in Quick COVID-19 Blood Screening Strategy

News

A new study suggests that COVID-19 affects the human body’s blood concentration levels of specific metabolites. Three metabolites identified in the study could act as biomarkers and hold potential to be measured through an inexpensive blood test to quickly screen patients for the disease.

READ MORE

Avoiding Side Effects Associated With Cancer Treatment

News

Researchers at the University of California, Irvine and Switzerland's Lausanne University Hospital/University of Luassanne (CHUV/UNIL) may have found a way to treat cancer without the onset of debilitating side effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE